UNSPSC 51292604: Ftormetazine

This classification denotes an antidepressant agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1P441EE1PH. European Medicines Agency schedules Ftormetazine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07822MIG. Ftormetazine generally arises in the molecular formula C21H22F3N3OS.

UNSPSC 51292604 Ftormetazine is a Commodity code that, based on recent state and local activity, describes pharmaceutical products and drug-related supplies acquired by public health jurisdictions. The recent solicitation under this code shows procurement of naloxone and drug deactivation systems — emergency medical supplies and harm-reduction equipment — rather than ftormetazine itself, indicating a mismatch between the code's nominal scope and what state and local governments are actually buying under it. Issuing bodies include county health departments and community health programs that support public health initiatives and emergency response capabilities.

Seminole County, Florida posted an IFB (Solicitation Number IFB60459723LAS) in June 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The bid deadline was July 26, 2023. The contract includes a two-year initial term with a one-year renewal option, fixed-fee pricing, and potential FEMA funding. Vendors must meet standard compliance requirements including drug-free workplace certification, E-Verify enrollment, workers' compensation and general liability insurance, and a three-month probationary period. The source provides no evidence of activity under this code outside Seminole County, and the mismatch between the code's nominal pharmaceutical scope and the actual procurement of emergency medical supplies suggests limited relevant recent opportunity volume under this particular UNSPSC designation.